These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2660308)

  • 41. Ultra-early endovascular embolization of ruptured cerebral aneurysm and the increased risk of hematoma growth unrelated to aneurysmal rebleeding.
    Egashira Y; Yoshimura S; Enomoto Y; Ishiguro M; Asano T; Iwama T
    J Neurosurg; 2013 May; 118(5):1003-8. PubMed ID: 23240702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
    J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases.
    Murayama Y; Malisch T; Guglielmi G; Mawad ME; Viñuela F; Duckwiler GR; Gobin YP; Klucznick RP; Martin NA; Frazee J
    J Neurosurg; 1997 Dec; 87(6):830-5. PubMed ID: 9384391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebral vasospasm in aneurysmal subarachnoid hemorrhage.
    Hirsh LF
    Postgrad Med; 1981 Apr; 69(4):71-9. PubMed ID: 7208403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebral vasospasm after an intracranial aneurysmal subarachnoid hemorrhage: a nursing perspective.
    Jackson LO
    Heart Lung; 1986 Jan; 15(1):14-20. PubMed ID: 3511009
    [No Abstract]   [Full Text] [Related]  

  • 46. Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage.
    Nibbelink DW; Torner JC; Henderson WG
    Stroke; 1975; 6(6):622-9. PubMed ID: 1198627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurosurgical management of intracranial aneurysms following unsuccessful or incomplete endovascular therapy.
    Minh T; Hwang PY; Nguyen KC; Ng I
    Br J Neurosurg; 2006 Oct; 20(5):306-11. PubMed ID: 17129879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controversies in the surgical treatment of ruptured intracranial aneurysms: the First Annual J. Lawrence Pool Memorial Research Symposium--controversies in the management of cerebral aneurysms.
    Komotar RJ; Zacharia BE; Mocco J; Connolly ES
    Neurosurgery; 2008 Feb; 62(2):396-407; discussion 405-7. PubMed ID: 18382317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group.
    Roos Y
    Neurology; 2000 Jan; 54(1):77-82. PubMed ID: 10636129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current management of aneurysmal subarachnoid hemorrhage guidelines from the Canadian Neurosurgical Society.
    Findlay JM
    Can J Neurol Sci; 1997 May; 24(2):161-70. PubMed ID: 9164696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Management of aneurysmal subarachnoid hemorrhage].
    Fujinaka T; Yoshimine T; Mashimo T
    Masui; 2012 Sep; 61(9):962-70; discussion 970-2. PubMed ID: 23012833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage.
    Bejjani GK; Bank WO; Olan WJ; Sekhar LN
    Neurosurgery; 1998 May; 42(5):979-86; discussion 986-7. PubMed ID: 9588541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.
    Petruk KC; West M; Mohr G; Weir BK; Benoit BG; Gentili F; Disney LB; Khan MI; Grace M; Holness RO
    J Neurosurg; 1988 Apr; 68(4):505-17. PubMed ID: 3280746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacologic management of subarachnoid hemorrhage.
    Quandt CM; de los Reyes RA; Diaz FG; Ausman JI
    Drug Intell Clin Pharm; 1982 Dec; 16(12):909-15. PubMed ID: 6129959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antifibrinolytic therapy and cerebral vasospasm.
    Haley EC; Torner JC; Kassell NF
    Neurosurg Clin N Am; 1990 Apr; 1(2):349-56. PubMed ID: 2136147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebral ischemia in the aneurysm patient.
    Kassell NF; Boarini DJ
    Clin Neurosurg; 1982; 29():657-65. PubMed ID: 7172572
    [No Abstract]   [Full Text] [Related]  

  • 57. Results and complications of surgical management of 809 intracranial aneurysms in 722 cases. Related and unrelated to grade of patient, type of aneurysm, and timing of surgery.
    Sundt TM; Kobayashi S; Fode NC; Whisnant JP
    J Neurosurg; 1982 Jun; 56(6):753-65. PubMed ID: 6804608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurological outcomes following intraprocedural rerupture during coil embolization of ruptured intracranial aneurysms.
    Stapleton CJ; Walcott BP; Butler WE; Ogilvy CS
    J Neurosurg; 2015 Jan; 122(1):128-35. PubMed ID: 25361491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subarachnoid hemorrhage from intracranial aneurysms. Surgical management and natural history of disease.
    Sundt TM; Whisnant JP
    N Engl J Med; 1978 Jul; 299(3):116-22. PubMed ID: 661871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging trend: new therapy for ruptured intracranial aneurysms.
    Check W
    JAMA; 1978 Nov; 240(20):2135-6, 2143. PubMed ID: 702711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.